HypertensionNCT00227201
The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans
An observational study of Hypertension, run by Weill Medical College of Cornell University at 1 site in United States.
Trial summary
The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension
- What is being tested?
- Self-affirmation intervention
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2003to May 2005
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients will be African-American adults 18 years or older who were diagnosed with poorly controlled hypertension as defined by the 6th Joint National Committee guidelines (systolic >140 and diastolic >90).
- Patients will also be eligible if they are taking any prescribed anti-hypertensive medications.
- Patients must be able to provide informed consent in English. Participants will be recruited from Cornell Internal Medicine Associates, the primary care and general medicine practice at Cornell Medical Center, the same site as the parent grant.
Who cannot join
- Patients who refused to participate.
- Patients who are unable to provide informed consent.
Trial locations and contacts
1 site in 1 country.
United States1 site
New York Presbyterian Hospital-Weill Medical College
New York, New York, 10021
About this study
The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure.
Read the detailed description
The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure. Through the use of qualitative interviews, the beliefs and attitudes toward complementary medicine of African Americans with hypertension will be elucidated.
- Conditions
- Hypertension
- Being tested
- Self-affirmation intervention
- Keywords
- African-American, Hypertension, Complementary medicine, Medication adherence
- Medical subject headings
- Hypertension, Medication Adherence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self-affirmation interventionBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
The impact of positive affect induction and self-affirmation on medication adherence and blood pressure control.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Sep 2005 (estimated)
- Study startJun 2003
- Study completionMay 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for HypertensionStudies of the same condition, open and under way.
- More trials run by Weill Medical College of Cornell UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Enrolment
- 60 participants
Sponsor and investigators
- Lead sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Investigators
- Jason Moore, Principal investigator, Weill Medical College of Cornell UniversityMary E Charlson, MD, Principal investigator, Weill Medical College of Cornell University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00227201
- Sponsor's protocol ID
- 0301005948
- Status last verified
- Apr 2008
- First submitted
- 23 Sep 2005
- Last updated
- 25 Apr 2008
- Results posted
- No
Publications
JA Moore, Factors that influenced medication adherence among African-Americans with hypertension, to be presented at the 12th Annual NHLBI Cardiovascular Minority Research Supplement Awardee Session, American Heart Association, November 2004.
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-Americans
- ClinicalTrials.gov ID
- NCT00227201
- Acronym / sponsor ID
- 0301005948
- Conditions
- Hypertension
- Keywords
- African-American, Hypertension, Complementary medicine, Medication adherence
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants
- Lead sponsor
- Weill Medical College of Cornell UniversityUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- Jun 2003
- Study completion
- May 2005
- First posted
- 27 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure.
Detailed description
The objective of this study is to better understand strategies used by African Americans with hypertension in order to control their blood pressure. Through the use of qualitative interviews, the beliefs and attitudes toward complementary medicine of African Americans with hypertension will be elucidated.
Study design
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients will be African-American adults 18 years or older who were diagnosed with poorly controlled hypertension as defined by the 6th Joint National Committee guidelines (systolic >140 and diastolic >90).
- Patients will also be eligible if they are taking any prescribed anti-hypertensive medications.
- Patients must be able to provide informed consent in English. Participants will be recruited from Cornell Internal Medicine Associates, the primary care and general medicine practice at Cornell Medical Center, the same site as the parent grant.
Key exclusion criteria (2 listed)
- Patients who refused to participate.
- Patients who are unable to provide informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Self-affirmation intervention | Behavioural | – |
Primary outcome
The impact of positive affect induction and self-affirmation on medication adherence and blood pressure control.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2008.
- BackgroundJA Moore, Factors that influenced medication adherence among African-Americans with hypertension, to be presented at the 12th Annual NHLBI Cardiovascular Minority Research Supplement Awardee Session, American Heart Association, November 2004.
Related trials for Hypertension
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
Not yet recruitingPhase 2/3
An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease
Enrolling by invitation
Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle
Pregnancy Related, Hypertension
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jason Moore principal investigator
Weill Medical College of Cornell University
Mary E Charlson, MD principal investigator
Weill Medical College of Cornell University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypertension, run by Weill Medical College of Cornell University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Apr 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The impact of positive affect induction and self-affirmation on medication adherence and blood pressure control.. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00227201, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2008.